Varian Medical Systems downgraded by UBS Group
$VAR
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
UBS Group downgraded Varian Medical Systems from to In-Line
Save time and jump to the most important pieces.
UBS Group downgraded Varian Medical Systems from to In-Line
UBS Group downgraded Varian Medical Systems from Buy to In-Line
UBS Group reiterated coverage of Varian Medical Systems with a rating of In-Line and set a new price target of $1.00
4 - VARIAN MEDICAL SYSTEMS INC (0000203527) (Issuer)
4 - VARIAN MEDICAL SYSTEMS INC (0000203527) (Issuer)
4 - VARIAN MEDICAL SYSTEMS INC (0000203527) (Issuer)
SC 13G/A - VARIAN MEDICAL SYSTEMS INC (0000203527) (Subject)
PALO ALTO, Calif., Aug. 5, 2021 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that cancer patients in Australia will be the first in the world to benefit from streamlined, coordinated cancer care facilitated by an upcoming release of the ARIA® oncology information system (OIS) with new multi-disciplinary functionality. Australia's Icon Group will become the first in the world to deploy this new system, which is scheduled for release in Australia and other global sites in early 2022. Icon plans to go live with its first location in 2022. After a successful deployment, the new ARIA system will serve as Icon's next-generation platform for enhancing clinical operatio
PALO ALTO, Calif., April 27, 2021 /PRNewswire/ -- Varian (NYSE:VAR), a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further strengthens the global partnership between Varian and Icon Group, together increasing access to care across regional and underserviced areas in Australia and Asia. The order is comprised of a variety of Varian linear accelerators and software including Halcyon™, TrueBeam®, and HyperArc™. These systems will be installed in new and existing Icon cancer centers in Australia to increase capacity and broaden
NEW YORK, April 15, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20: S&P MidCap 400 constituent PTC Inc. (NASD:PTC) will replace Varian Medical Systems Inc. (NYSE:VAR) in the S&P 500, and Lattice Semiconductor Co. (NASD:LSCC) will replace PTC in the S&P MidCap 400. Siemens Healthineers AG (XETR: SHL) acquired Varian Medical Systems Inc. in a deal that closed today, April 15. Progyny Inc. (NASD:PGNY) will replace Domtar Corp. (NYSE:UFS) in the S&P MidCap 400, and Domtar will replace NIC Inc. (NASD:EGOV) in the S&P SmallCap 600. S&P 500 constituent Tyler T
15-12B - VARIAN MEDICAL SYSTEMS INC (0000203527) (Filer)
25-NSE - VARIAN MEDICAL SYSTEMS INC (0000203527) (Subject)
S-8 POS - VARIAN MEDICAL SYSTEMS INC (0000203527) (Filer)